On 31st December 2019, the World Health Organization (WHO) China Country Office was informed of cases of pneumonia of unknown etiology (unknown cause) detected in Wuhan City, Hubei Province of China. On 7th January 2020, Chinese authorities identified a new strain of Coronavirus as the causative age...nt for the disease. The virus has been renamed by WHO as SARS-CoV-2 and the disease caused by it as COVID-19. The disease since its first detection in China has now spread to over 200 countries/territories, with reports of local transmission happening in more than 160 of these countries/territories. As per WHO (as of 1st April, 2020), there has been a total of 823626 confirmed cases and 40598 deaths due to COVID-19 worldwide.
In India, as on 2nd April, 2020, 1965 confirmed cases (including 51 foreign nationals) and 50 deaths reported from 29 States/UTs. Large number of cases has been reported from Delhi, Karnataka, Kerala, Maharashtra, Rajasthan, Tamil Nadu, Telangana and Uttar Pradesh.
more
This report highlights key achievements registered by the Ministry of Health, affiliated institutions, implementing agencies both at central and decentralized levels in 2013-2014. Generally, the Health Sector accomplishments and programs routine data for 2013-2014 confirm that Rwanda maintains its p...rogress towards the realization of health-related MDGs and national health targets as well.
more
Examination of the business behaviour of Boehringer Ingelheim, Bayer and Baxter in Uganda
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b...y COVID-19. The WHO Global TB Programme, along with WHO regional and country offices, developed this note in response to questions received from Member States and other partners since the start of the pandemic. The note includes references to other published WHO information products relevant to TB practitioners. WHO continues to monitor the situation closely for any changes that may influence this note and will issue updates should any factors change.
more
Towards a Healthier Botswana
This is an update of a seven-year TB and Leprosy national strategic plan (TBL-NSP), which extends from 2013 to 2020. The update focuses on the plan covering from 2017-20 and is based on the 2017 external mid-term programme review key findings and recommendations; the global and national End TB strat...e-gies and targets; stakeholders consultation and recent revision of the national TB guidelines.
more
Examination of the business behavior of Boehringer Ingelheim, Bayer and Baxter in India
The goal of the United States Government for the President's Emergency Plan for AIDS Relief (PEPFAR) in Mozambique is to support country efforts to achieve epidemic control by 2020 through evidence-based policies and interventions to drive progress and save
lives. This document details PEPFAR's op...erational plan in Mozambique.
more
23rd February 2017, Protea Hotel Thuringerhof, Windhoek | 2017 Namibia ART Guidelines: Summary of New and Old Recommendations
Muitos países já demonstraram que a transmissão por COVID- 19 de uma pessoa para outra pode ser desacelerada ou interrompida. Essas ações salvaram vidas e deram ao restante do mundo mais tempo para se preparar para a chegada da COVID-19: prontidão dos sistemas de resposta a emergências; aumen...to da capacidade de detecção e assistência aos pacientes; garantia de espaço, insumos e equipes necessárias nos hospitais, e desenvolvimento de intervenções médicas que salvam vidas. Todos os países devem urgentemente tomar as medidas necessárias para desacelerar a disseminação e evitar que seus sistemas de saúde fiquem sobrecarregados, em função de pacientes gravemente doentes por COVID-19.
more
Este documento apresenta uma orientação provisória aos Estados Membros para uma rápida investigação de casos suspeitos de COVID-19 após um alerta ou sinal. Tem como propósito ser utilizada por autoridades de saúde locais, regionais ou nacionais como considerações para a investigação de ...casos de COVID-19. Não deve ser considerada como um guia abrangente para investigação do surto. Há orientações detalhadas disponíveis para a investigação de surto de outros patógenos respiratórios, incluindo o MERS-CoV e influenza. Maiores informações sobre a investigação de surto para a COVID-19 podem ser encontradas no OpenWHO website.Essa orientação pode ser implementada em diferentes países com vários recursos e padrões epidemiológicos e deve ser adaptada da forma mais adequada. Este documento tem como objetivo descrever os componentes específicos necessários para uma investigação. Ela é elaborada com base no conhecimento sobre a epidemia da COVID-19 e considerações semelhantes para outros patógenos respiratórios, incluindo o vírus MERS-CoV e influenza. A OMS continuará atualizando essas recomendações à medida que surgirem mais informações.
more
Центр лечения тяжелых острых респираторных инфекцийПрактическое руководство по организации центра лечения ТОРИ ицентра проведения скрининга на ТОРИ на базе мед...цинских учреждений
more